Lücke R, Benz R, Kraus H
Universitäts-Frauenklinik Ulm.
Geburtshilfe Frauenheilkd. 1987 Dec;47(12):846-9. doi: 10.1055/s-2008-1036059.
The tumor markers Ca 125 and serum ribonuclease were determined simultaneously in 35 patients with primary ovarian cancer during therapy and follow-up. In patients with second-look operation, Ca 125 and ribonuclease correlated well with the presence of metastases. In our experience the marker Ca 125 appeared to be superior to serum ribonuclease levels. Recurrence may be detected equally well with both markers.
在35例原发性卵巢癌患者的治疗及随访过程中，同时测定了肿瘤标志物Ca 125和血清核糖核酸酶。在接受二次探查手术的患者中，Ca 125和核糖核酸酶与转移灶的存在密切相关。根据我们的经验，标志物Ca 125似乎优于血清核糖核酸酶水平。两种标志物对复发的检测效果相当。
